Redeye saw lower sales than expected, although there was growth but not as much as we expected.
Ferronordic reported a mixed set of Q4 2024 numbers, with sales clearly beating our expectation, lar...
Next milestones: finalisation of environmental permit.
New partnership with major European defence company Expected to materialise in orders relatively nea...
We cut '25e and '26e EBITA by 21% and 5% on weak margin Margins to remain weak in H1'25, but we thin...
We expect positive organic growth from H2'25 EBIT estimates cut 2%, mainly on FX Share is trading at...
Aktiemarknaden verkar ha haft högre förväntningar med tanke på dagens kursreaktion, men ur vårt pers...
Redeye leaves a short comment on yesterday's announcement that all patients in the ProTrans V study ...
Strong beat on capital markets, underlying cost better AUM miss and crypto prices down since last re...
Zoomability publicerade den 20 februari 2025 bolagets delårsrapport för årets fjärde kvartal 2024.
Försiktigheten består Nettoomsättningen minskade med 20,8 procent, där den största överraskningen va...
Titania publicerade den 20 februari år 2025 Bolagets delårsrapport för det fjärde kvartalet år 2024.
I dag offentliggjorde Angler Gaming sin delårsrapport för kv4 2024.
Prostatype Genomics har kompletterat sin ansökan om att inkluderas i det amerikanska ersättningssyst...
Marimekko ended its year on a high note as Q4 figures were better than we expected for both sales an...
Redeye comments on Medivir’s final phase IIa data of fostrox + Lenvima in second-line liver cancer (...
Redeye states that the Q4 report came in above our estimates on both sales and EBITDA, and Sivers re...
Nosa Plugs AB ("Nosa Plugs" or the "Company") is a medical technology company that has developed int...
Redeye’s comments on Xbrane following its year-end report, which showed negative revenue growth both...
Redeye states InfraCom’s Q4 2024 report came in better than anticipated and is another print showing...
